Abstract
Glycogen storage disease (GSD)-1b has been associated with neutropenia and abnormalities of neutrophil function. Many individuals with GSD-1b manifest chronic gastrointestinal inflammation. Our study was performed to precisely establish the type, frequency, and spectrum of gastrointestinal disease in patients with GSD-1b. We established a medical database of 36 individuals affected with GSD-1b, utilizing patients at our center, disease registries, and direct contacts with North American referral centers specializing in genetic disorders. Records were reviewed, focusing on documentation of gastrointestinal involvement. Gastrointestinal symptoms or manifestations were present in approximately 75% of the patients, including chronic abdominal pain and diarrhea, perianal fistula or abscess, and oral aphthous ulceration. Of patients identified, 28% had documented inflammatory bowel disease (IBD) and an additional 22% of patients had symptoms highly suggestive of IBD, but had not undergone comprehensive diagnostic evaluation. Gastrointestinal involvement was found to be indistinguishable from idiopathic Crohn disease (CD) by detailed review of clinical, radiologic, endoscopic and histopathologic findings. Many patients had significant improvement or resolution of gastrointestinal disease in response to G-CSF treatment. The expression of CD in patients with GSD-1b may be delayed or prevented by G-CSF treatment.Conclusion: a strong association exists between glycogen storage disease type 1b and inflammatory bowel disease. A high index of suspicion for Crohn disease should be applied in evaluating patients with glycogen storage disease type 1b and intestinal symptoms. These results provide further support for the hypothesis that some forms of inflammatory bowel disease may result from impaired mucosal innate immunity. Additional investigations into the intestinal disease in glycogen storage disease type 1b may be directly relevant to the etiology and treatment of idiopathic Crohn disease.
Similar content being viewed by others
Abbreviations
- CD :
-
Crohn disease
- G-CSF :
-
granulocyte colony-stimulating factor
- GSD :
-
glycogen storage disease
- IBD :
-
inflammatory bowel disease
References
Ahlin A, De Boer M, Roos D, Leusen J, Smith CI, Sundin U, Rabbani H, Palmblad J, Elinder G (19995) Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr 84: 1386–1394
Ambruso DR, McCabe ER, Anderson D, Beaudet A, Ballas LM, Brandt IK, Brown B, Coleman R, Dunger DB, Falletta JM et al (1985) Infectious and bleeding complications in patients with glycogenosis Ib. Am J Dis Child 139: 691–697
Bashan N, Hagai Y, Potashnik R, Moses SW (1988) Impaired carbohydrate metabolism of polymorphonuclear leukocytes in glycogen storage disease Ib. J Clin Invest 81: 1317–1322.
Beaudet AL, Anderson DC, Michels VV, Arion WJ, Lange AJ (1980) Neutropenia and impaired neutrophil migration in type IB glycogen storage disease. J Pediatra 97: 906–910
Chen YT, Burchell A (1997) Glycogen storage diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The metabolic and molecular bases of inherited disease CD-ROM. McGraw-Hill, New York
Farmer RG, Hawk WA, Turnbull RB Jr (1975) Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology 68: 627–635
Kilpatrick L, Garty BZ, Lundquist KF, Hunter K, Stanley CA, Baker L, Douglas SD, Korchak HM (1990) Impaired metabolic function and signaling defects in phagocytic cells in glycogen storage disease type 1b. J Clin Invest 86: 196–202
Korzenik JR, Dieckgraefe BK (2000) Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig Dis Sci 45: 1121–1129
Koven NL, Clark MM, Cody CS, Stanley CA, Baker L, Douglas SD (1986) Impaired chemotaxis and neutrophil (polymorphonuclear leukocyte) function in glycogenosis type IB. Pediatr Res 20: 438–442
Marcolongo P, Barone V, Priori G, Pirola B, Giglio S, Biasucci G, Zammarchi E, Parenti G, Burchell A, Benedetti A, Sorrentino V (1998) Structure and mutation analysis of the glycogen storage disease type Ib gene. FEBS Lett 436: 247–250
Stenson WF, MacDermott RP (1991) Inflammatory bowel disease. In: Yamada T, Alpers DH, Owyang C, Powell DW, Silverstein FE (eds), Textbook of gasteroenterology, vol 2. Lippincott, Philadelphia, pp 1588–1645
Verhoeven AJ, Viser G, van Zwieten R, Gruszczynska B, Tien Poll-The DW, Smit SPA (1999) A convenient diagnostic function test of peripheral blood neutrophils in glycogen storage disease type Ib. Pediatr Res 45: 881–885
Visser G, Rake JP, Fernandes J, Labrune P, Leonard JV, Moses S, Ullrich K, Smit GPA (2000) Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease Type I. J Pediatr 137: 187–191
Wolfsdorf JI, Holm IA, Weinstein DA (1999) Glycogen storage diseases. Phenotypic, genetic, and biochemical characteristics, and therapy. Endocrinol Metab Clin North Am 28: 801–823
Author information
Authors and Affiliations
Corresponding author
Additional information
Published online: 13 August 2002
On behalf of the North American Glycogen Storage Disease Study Group Members of the North American Glycogen Storage Disease Study Group: John Bellmont, Steve Cederbaum, Y.T. Chen, Peter Chenaille, Sechin Cho, George E. Hoganson, R. D. Holmes. Eric Hoover, Simon Horslen, James Keating, Douglas Kerr, Mark Ludman, Martin G. Martin, Dietrich Matern, Seymour Packman, Howard Parsons, Thomas Roe, Phil Rosenthal, C. R. Scott, Liz Shorey, Alfred E. Slonim, Charles Stanley, Micheline T. Ste-Marie, Robert D. Steiner, Holley Arp Swain, Steven Werlin, Joseph I. Wolfsdorf, and R. C. Woodman.
Rights and permissions
About this article
Cite this article
Dieckgraefe, B.K., Korzenik, J.R., Husain, A. et al. Association of glycogen storage disease 1b and Crohn disease: results of a North American survey. Eur J Pediatr 161, S88–S92 (2002). https://doi.org/10.1007/BF02680002
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02680002